THERAPEUTICS ACQUISITION COR filings

SEC filings by THERAPEUTICS ACQUISITION COR (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2023-12-27SILBER ALLAN CPOINT Biopharma Global Inc.00.0%EDGAR
SC 13D/A2023-12-20BIOTECHNOLOGY VALUE FUND L PPOINT Biopharma Global Inc.00.0%EDGAR
SC 13D2023-11-06BIOTECHNOLOGY VALUE FUND L PPOINT Biopharma Global Inc.8,974,2458.5%EDGAR
SC 13D/A2023-10-03SILBER ALLAN CPOINT Biopharma Global Inc.9,316,1848.8%EDGAR
SC 13G/A2023-02-14BIOTECHNOLOGY VALUE FUND L PPOINT Biopharma Global Inc.4,916,3064.7%EDGAR
SC 13G2023-02-03BlackRock Inc.POINT Biopharma Global Inc.5,393,4385.1%EDGAR
SC 13D/A2022-11-22SILBER ALLAN CPOINT Biopharma Global Inc.9,231,3688.7%EDGAR
SC 13D/A2022-09-26RA CAPITAL MANAGEMENT, L.P.POINT Biopharma Global Inc.00.0%EDGAR
SC 13G2022-09-26BIOTECHNOLOGY VALUE FUND L PPOINT Biopharma Global Inc.2,991,2132.9%EDGAR
SC 13D/A2022-09-16RA CAPITAL MANAGEMENT, L.P.POINT Biopharma Global Inc.9,003,0188.6%EDGAR
SC 13D/A2022-08-29RA CAPITAL MANAGEMENT, L.P.POINT Biopharma Global Inc.9,003,0189.9%EDGAR
SC 13G/A2022-02-15PERCEPTIVE ADVISORS LLCPOINT Biopharma Global Inc.1,193,9951.3%EDGAR
SC 13G/A2022-02-14PRICE T ROWE ASSOCIATES INC /MD/POINT Biopharma Global Inc.00.0%EDGAR
SC 13G/A2022-02-14BIOTECHNOLOGY VALUE FUND L PPOINT Biopharma Global Inc.1,504,8261.7%EDGAR
SC 13G/A2022-02-14Boxer Capital, LLCPOINT Biopharma Global Inc.2,500,0002.8%EDGAR
SC 13G/A2022-02-14RIVERVIEW GROUP LLCPOINT Biopharma Global Inc.5,2070.0%EDGAR
SC 13G/A2022-02-11Avoro Capital Advisors LLCPOINT Biopharma Global Inc.00.0%EDGAR
SC 13G/A2022-02-11SUVRETTA CAPITAL MANAGEMENT, LLCPOINT Biopharma Global Inc.2,672,8633.0%EDGAR
SC 13G/A2022-02-07FRANKLIN RESOURCES INCPOINT Biopharma Global Inc.773,7000.9%EDGAR
SC 13G/A2022-02-04WELLINGTON MANAGEMENT GROUP LLPPOINT Biopharma Global Inc.00.0%EDGAR